课题基金 / 基金详情

Creation of Substitution Labile Pyrazolylborate Metal Complexes

Creation of Substitution Labile Pyrazolylborate Metal Complexes
取代不稳定的吡唑基硼酸盐金属配合物的制备
批准号:
09640675
负责人:
YAMAZAKI Hiroshi
金额:
$0.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

YAMAZAKI Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
(1)制备了Bis[dihydrobis(3,5-bis(trifluoromethyl)pyrazolyl)borate]cobalt,并用X-射线单晶分析确定了其结构。钴中心以方形平面的方式配位到四个吡唑基,并在轴向位置与两个B-H基团配位,形成完全扭曲的八面体构型。这与已知的未取代和3,5-二甲基取代的吡唑基硼酸盐衍生物形成了鲜明的对比。(2)合成了Bis(triphenylphosphine)[dihydrobis(3,5-R_2-pyrazolyl)borate]ruthenium氢化物(R=H,Me,Cf_3),并用X-射线单晶衍射法确定了它们的结构。根据与CO的反应活性,估算了相互作用强度的大小顺序为:Me≫H*Cf_3。(3)合成了双(三苯基膦)[二氢双(3,5-R_2-吡唑基)硼酸盐]Rh配合物(R=H,Me,CF_3),并通过X-射线晶体分析确定了其结构。四个吡唑基以方形平面图的方式配位于Rg中心。(4)合成了Eta、3-烯丙基和indenyl[hydrotris(3,5-R_2-pyrazolyl)borate]palladium(R=H,Me,Cf_3)配合物,并用X-射线单晶分析确定了它们的结构。用核磁共振波谱研究了它们在溶液中的流动行为。
英文摘要
(1) Bis[dihydrobis(3,5-bis(trifluoromethyl)pyrazolyl)borate]cobalt was prepared and the structure was determined by X ray crystallographic analysis. The cobalt center is coordinated to four pyrazolyl groups in a square planner manner and to two B-H groups at the axial positions forming totally a distorted octahedral configuration. This is in marked contrast to those of known non-substituted and 3, 5-dimethyl substituted pyrazolylborate derivatives which appear inn a tetrahedral configuration Similar nickel complex having a B-H-M agostic interaction was prepared.(2) Bis(triphenylphosphine)[dihydrobis(3,5-R_2-pyrazolyl)borate]ruthenium hydrides (R=H, Me, CF_3) were prepared and the structures containing a B-H-Ru agostic interaction were determined by X ray crystallography. Based on the reactivity with CO, strength of the agostic interaction was estimated to decrease in the order, Me> H * CF_3.(3) Bis(triphenylphosphine)[dihydrobis(3, 5-R_2-pyrazolyl)borate]rhodium complexes (R=H, Me, CF_3) were prepared and the structures were determined by X ray crystallographic analysis. The rhodium centers are coordinated in a square planner manner to the four pyrazolyl groups. No B-H-Rh agostic interactions were observed in these complexes.(4) eta^3-Allyl and indenyl[hydrotris(3,5-R_2-pyrazolyl)borate]palladium complexes (R=H, Me, CF_3) were prepared and the structures were determined by X ray crystallographic analysis. Their fluxional behavior in solution were studied by NMR spectroscopy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Relevance to bioactivation and toxicity of thalidomide, pomalidomide, and lenalidomide by human cytochrome P450 3A enzymes in cultured placental cells and humanized-liver mice
  • 批准号:
    17K08425
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2017
  • 负责人:
    YAMAZAKI Hiroshi
  • 依托单位:
Mechanisms of resistance to molecularly targeted drugs for oral squamous cell carcinoma and investigation of countermeasures
  • 批准号:
    16K11732
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.08万
  • 财政年份:
    2016
  • 负责人:
    YAMAZAKI Hiroshi
  • 依托单位:
Development of Effective Markers for Resistance of Oral Squamous Cell Carcinoma to Molecular-targeting Drugs
  • 批准号:
    25463120
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.16万
  • 财政年份:
    2013
  • 负责人:
    YAMAZAKI Hiroshi
  • 依托单位:
Thalidomide increases cytochrome P450 activity and drug metabolism in liver through direct activation of nuclear receptor CAR and PXR
  • 批准号:
    23590200
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.49万
  • 财政年份:
    2011
  • 负责人:
    YAMAZAKI Hiroshi
  • 依托单位:
海外基金